ALX Oncology Competitors and Similar CompaniesClear all

ALX Oncology's competitors and similar companies include DNAtriX, Vyriad and Century Therapeutics.

	ALX Oncology ALX Oncology is a company that develops protein-based therapeutics intended to help in cancer treatment.	DNAtriX DNAtrix is a biotechnology company that provides virus-driven immunotherapies for cancer.	Vyriad Vyriad is a company that develops a biopharmaceutical platform designed to cure cancer.	Century Therapeutics Century Therapeutics is a biotech company that develops therapies to treat cancer.
Founding Date	Founding Date 2015	Founding Date 2005	Founding Date 2016	Founding Date 2018
Type	Type Public	Type Private	Type Private	Type Public
Tags	Tags Healthcare biotech healthtech oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech healthtech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy
Locations	Locations Burlingame, US HQ Dublin 2, IE	Locations Houston, US HQ San Diego, US	Locations Rochester, US HQ	Locations Philadelphia, US HQ Hamilton, CA Seattle, US
Employees	Employees 743% increase	Employees 3	Employees 49	Employees 107
Valuation ($)	Valuation ($) 77.5 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 115.2 m
Financial
Net income	Net income ($101.7m) (FY, 2025)	Net income N/A	Net income N/A	Net income ($9.6m) (FY, 2025)
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 15.5m (almost 8 years ago)	Latest funding round $ 24.4m (over 6 years ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 166m	Total funding raised $ 54.2m	Total funding raised $ 24.4m	Total funding raised $ 410m